Close Menu

The GET conference is underway in Cambridge and James Watson, one of the "personal genome pioneers" at the meeting, is letting his thoughts be known during the discussions. At this time in his life, Watson says he wasn't worried about what he might have learned from getting his genome sequenced. "If I were 20 I wouldn't want to know because you just worry. At 80 I don't worry if I'm going to get cancer," Watson said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.